Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Cash from Operations (2021 - 2025)

Medicinova (MNOV) has disclosed Cash from Operations for 7 consecutive years, with 1098829.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Operations changed N/A to 1098829.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 9725474.0, a N/A change, with the full-year FY2025 number at 9810061.0, up 7.83% from a year prior.
  • Cash from Operations was 1098829.0 for Q4 2025 at Medicinova, up from 3783661.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 1126936.0 in Q2 2021 to a low of 3868248.0 in Q1 2024.
  • A 5-year average of 2438197.5 and a median of 2913276.5 in 2021 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: grew 14.78% in 2023, then crashed 48.16% in 2024.
  • Medicinova's Cash from Operations stood at 3638966.0 in 2021, then decreased by 2.46% to 3728400.0 in 2022, then skyrocketed by 86.61% to 499060.0 in 2023, then plummeted by 307.18% to 2032054.0 in 2024, then skyrocketed by 45.93% to 1098829.0 in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Cash from Operations are 1098829.0 (Q4 2025), 3783661.0 (Q1 2025), and 2032054.0 (Q3 2024).